Evidence map›Paper›PMID 41853885›Full record

ArticleHuman brain mapping2026

Brain Age Estimation on T2-FLAIR Scans for Application to Multiple Sclerosis.

Jordan Colman, Giuseppe Pontillo, Olivia Goodkin, Michael A Foster, Nima Mahmoudi, Mike P Wattjes, Arturo Brunetti, Gabriel Gonzalez-Escamilla, Sergiu Groppa, Einar August Høgestøl and 24 more

Abstract readMulticenter Study
In one paragraph

Article in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Jordan ColmanUCL Hawkes Institute, University College London, London, UK.
Giuseppe PontilloUCL Hawkes Institute, University College London, London, UK.
Olivia GoodkinUCL Hawkes Institute, University College London, London, UK.
Michael A FosterQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0001-7201-7475
Nima MahmoudiDepartment of Neuroradiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Mike P WattjesDepartment of Neuroradiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.
Arturo BrunettiDepartment of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
Gabriel Gonzalez-EscamillaMovement Disorders, Neurostimulation and Neuroimaging, University Medicine Mainz, Mainz, Germany.ORCID 0000-0002-7209-1736
Sergiu GroppaMovement Disorders, Neurostimulation and Neuroimaging, University Medicine Mainz, Mainz, Germany.
Einar August HøgestølDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Lars T WestlyeDepartment of Psychology, University of Oslo, Oslo, Norway.ORCID 0000-0001-8644-956X
Silvia MessinaNuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Jacqueline PalaceNuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Rosa CorteseDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Nicola De StefanoDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Àlex RoviraSection of Neuroradiology, Department of Radiology, Hospital Universitari Vall D'hebron, Barcelona, Spain.
Jaume Sastre-GarrigaSection of Neuroradiology, Department of Radiology, Hospital Universitari Vall D'hebron, Barcelona, Spain.
Stefan RopeleDepartment of Neurology, Medical University of Graz, Graz, Austria.
Christian EnzingerDepartment of Neurology, Medical University of Graz, Graz, Austria.
Maria A RoccaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.ORCID 0000-0003-2358-4320
Massimo FilippiVita-Salute San Raffaele University, Milan, Italy.ORCID 0000-0002-5485-0479
Barbara BellenbergInstitute of Neuroradiology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.ORCID 0000-0001-7484-6787
Carsten LukasInstitute of Neuroradiology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
Massimiliano CalabreseDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Marco CastellaroDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Tomas UherDepartment of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Manuela VaneckovaDepartment of Radiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Ahmed ToosyQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
Olga CiccarelliQueen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
Tarek YousryLysholm Department of Neuroradiology, UCLH National Hospital for Neurology and Neurosurgery, London, UK.
Ferran PradosUCL Hawkes Institute, University College London, London, UK.
Frederik BarkhofUCL Hawkes Institute, University College London, London, UK.
James H ColeUCL Hawkes Institute, University College London, London, UK.ORCID 0000-0003-1908-5588
MAGNIMS Study Group

Funding

Czech Ministry of EducationCzech Ministry of Health RVO VFN 64165ECTRIMS-MAGNIMS and ESNREuropean UnionGerman Federal Ministry for Education and Research, BMBF, German Competence Network Multiple Sclerosis 01GI1601IMEDDAY pharmaceutical company MS-ON-NCT02220244MEDDAY pharmaceutical company MS-SPI2-NCT02936037Medical Research Council MR/S026088/1MS Society of Great Britain and Northern IrelandNational Institute for Neurological Research LX22NPO5107National Multiple Sclerosis SocietyNIHR Biomedical Research Centre 541/CAP/OC/818837NIHR-HTANIHR UCLH Biomedical Research CentreRosetrees Trust A1332Rosetrees Trust PGL21/10079
6 · The paper itself

Abstract

The brain-predicted age difference (brain-PAD) is associated with measures of clinical interest in people with multiple sclerosis (pwMS). Most brain age models rely on 3D T1-weighted scans, which are not routinely acquired in MS clinical practice, limiting their potential for clinical translation. We aimed to develop a model predicting brain age using T2-FLAIR, the core sequence for MS diagnosis and monitoring, and validate the resulting brain-PAD values as a biomarker of MS severity and progression. We collected 3D T2-FLAIR and 3D T1-weighted brain MRI scans to compose (i) a multicentre cohort of healthy participants for brain age modeling, and (ii) a single-centre cohort of pwMS and healthy controls for external validation. We trained and evaluated 3D convolutional neural network models predicting brain age from T2-FLAIR or T1-weighted images. Models were compared using t-tests based on bootstrapped standard errors. Saliency maps were obtained with the SmoothGrad method to visualize regions that were most important for the predictions. Finally, using a linear model framework, we clinically validated the resulting brain-PAD metric by assessing its relationship with diagnosis (MS versus healthy controls), clinical phenotype, disease duration, and physical disability as measured with the Expanded Disability Status Scale (EDSS), adjusting for age and sex. The Inception-ResNet-V2 model based on T2-FLAIR scans yielded accurate brain age predictions (test set MAE = 3.31 years, R

Indexed as

AgingBrainMagnetic Resonance ImagingMultiple SclerosisNeuroimagingAdultConvolutional Neural NetworksDisease ProgressionFemaleHumansMaleMiddle Aged

Identifiers

PMID41853885
PMCPMC13081688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.